Nielsen BioSciences
Closed portfolio snapshot
According to ClinicalTrials.gov-derived indexes, Nielsen BioSciences sits in the upper quartile of US sponsors by registered trial count (#2,411 of 15,742 sponsors by registered trial count).
Nielsen BioSciences: 5 sponsored US clinical trials, none currently recruiting.
Nielsen BioSciences sponsors 5 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 5 completed. 2 of these trials are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Common Warts (Verruca Vulgaris), with 1 trials.
Upper-quartile sponsor footprint
Nielsen BioSciences sits in the upper quartile of the sponsor corpus (#2,411 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
5 total, page 1 of 1
Candin for the Treatment of Common Warts
NCT05889845
Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)
NCT02393417
Candin Safety & Efficacy Study for the Treatment of Warts
NCT01757392
Safety, False-Positive Reactions and Sensitizing Properties of Leishmania Tropica Skin Test Antigen
NCT00633009
A Multi-center Study of Spherule-Derived Coccidioidin
NCT00690092
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 3 |
| Phase 3 | 2 |
Therapeutic Areas
How the Nielsen BioSciences archive is shaped
5 indexed studies, none listed as recruiting (0% open); 5 completed (100%).
Phase mix: 2 late (III/IV) vs 3 early (I/II) (balanced across stages).
Top condition: Common Warts (Verruca Vulgaris) (1 trial), 2 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Nielsen BioSciences: archived-pipeline peers nationwide
Peers matched on 5 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Nielsen BioSciences sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 5 archived trials
- 4YouandMe · 5 trials · 0% recruiting
- Abbott Rapid Dx · 5 trials · 0% recruiting
- Access Business Group · 5 trials · 0% recruiting
- Acera Surgical · 5 trials · 20% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Nielsen BioSciences page
5 registered trials is a research-attention snapshot, not an endorsement of Nielsen BioSciences or any single study.
- None of Nielsen BioSciences's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Common Warts (Verruca Vulgaris) is the condition Nielsen BioSciences studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Common Warts (Verruca Vulgaris) trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Nielsen BioSciences pipeline card: 5 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.